{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:01:48Z","timestamp":1769065308314,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jiph.2021.01.016","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T21:26:31Z","timestamp":1612905991000},"page":"611-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents"],"prefix":"10.1016","volume":"14","author":[{"given":"Mohammad Z.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qamar","family":"Zia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anzarul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar M.","family":"Almarfadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Banawas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keshav L.","family":"Ameta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafiul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2021.01.016_bib0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jiph.2021.01.016_bib0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jiph.2021.01.016_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104212","article-title":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event","volume":"79","author":"Paraskevis","year":"2020","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.jiph.2021.01.016_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2021.01.016_bib0025","article-title":"Coronavirus genome structure and replication","volume":"287","author":"Brian","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jiph.2021.01.016_bib0030","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.2174\/138161206779010369","article-title":"Drug design targeting the main protease, the Achilles\u2019 heel of coronaviruses","volume":"12","author":"Yang","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jiph.2021.01.016_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2021.01.016_bib0040","doi-asserted-by":"crossref","DOI":"10.3201\/eid1006.030852","article-title":"Epidemiologic clues to SARS origin in China","volume":"10","author":"Xu","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiph.2021.01.016_bib0045","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"de Groot","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jiph.2021.01.016_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2021.01.016_bib0055","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jiph.2021.01.016_bib0060","doi-asserted-by":"crossref","DOI":"10.1111\/febs.12936","article-title":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design","volume":"281","author":"Hilgenfeld","year":"2014","journal-title":"FEBS J"},{"key":"10.1016\/j.jiph.2021.01.016_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/md18040225","article-title":"Putative inhibitors of SARS-COV-2 main protease from a library of marine natural products: a virtual screening and molecular modeling study","volume":"18","author":"Gentile","year":"2020","journal-title":"Mar Drugs"},{"key":"10.1016\/j.jiph.2021.01.016_bib0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M pro from COVID-19 virus and discovery of its inhibitors","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jiph.2021.01.016_bib0075","first-page":"1","article-title":"Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking","author":"Chang","year":"2020","journal-title":"Preprints"},{"key":"10.1016\/j.jiph.2021.01.016_bib0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jiph.2021.01.016_bib0085","first-page":"1","article-title":"Identifying novel inhibitor of quorum sensing transcriptional regulator (SdiA) of Klebsiella pneumoniae through modelling, docking and molecular dynamics simulation","author":"Ahmed","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jiph.2021.01.016_bib0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.saa.2018.11.045","article-title":"Investigation on the binding of aloe-emodin with tyrosinase by spectral analysis and molecular docking","volume":"211","author":"Zeng","year":"2019","journal-title":"Spectrochim Acta A: Mol Biomol Spectrosc"},{"key":"10.1016\/j.jiph.2021.01.016_bib0095","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1080\/07391102.2015.1094411","article-title":"Interaction of meropenem with \u2018N\u2019 and \u2018B\u2019 isoforms of human serum albumin: a spectroscopic and molecular docking study","volume":"34","author":"Rehman","year":"2016","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jiph.2021.01.016_bib0100","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.jiph.2021.01.016_bib0105","doi-asserted-by":"crossref","DOI":"10.1002\/prot.23106","article-title":"The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling","volume":"79","author":"Li","year":"2011","journal-title":"Proteins Struct Funct Bioinform"},{"key":"10.1016\/j.jiph.2021.01.016_bib0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.jiph.2021.01.016_bib0115","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1103\/PhysRevE.61.4769","article-title":"Nos\u00e9-Hoover chain method for nonequilibrium molecular dynamics simulation","volume":"61","author":"Bra\u0144ka","year":"2000","journal-title":"Phys Rev E: Stat Phys Plasmas Fluids Relat Interdiscip Top"},{"key":"10.1016\/j.jiph.2021.01.016_bib0120","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"Martyna","year":"1994","journal-title":"J Chem Phys"},{"key":"10.1016\/j.jiph.2021.01.016_bib0125","first-page":"1","article-title":"Potential inhibitor of COVID-19 main protease (M pro) from several medicinal plant compounds by molecular docking study","author":"Khaerunnisa","year":"2020","journal-title":"Preprints"},{"key":"10.1016\/j.jiph.2021.01.016_bib0130","article-title":"Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA","author":"Adem","year":"2020","journal-title":"Preprints"},{"key":"10.1016\/j.jiph.2021.01.016_bib0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jiph.2013.09.001","article-title":"Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis","volume":"7","author":"Ahmad","year":"2014","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiph.2021.01.016_bib0140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","article-title":"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"10","author":"Caminero","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2021.01.016_bib0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.20506\/rst.31.1.2095","article-title":"Antibiotics that affect the ribosome","volume":"31","author":"Lambert","year":"2012","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.jiph.2021.01.016_bib0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bcp.2014.07.002","article-title":"Troxerutin improves hepatic lipid homeostasis by restoring NAD+-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice","volume":"91","author":"Zhang","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jiph.2021.01.016_bib0155","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1600-0463.2004.apm1120908.x","article-title":"Treatment of the common cold with troxerutin","volume":"112","author":"Turner","year":"2004","journal-title":"APMIS"},{"key":"10.1016\/j.jiph.2021.01.016_bib0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.phymed.2004.01.007","article-title":"Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin","volume":"12","author":"Adam","year":"2005","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jiph.2021.01.016_bib0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11010-005-8052-3","article-title":"Protection of cellular DNA from \u03b3-radiation-induced damages and enhancement in DNA repair by troxerutin","volume":"280","author":"Maurya","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jiph.2021.01.016_bib0170","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s11095-005-6250-z","article-title":"Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease","volume":"22","author":"Kim","year":"2005","journal-title":"Pharm Res"},{"key":"10.1016\/j.jiph.2021.01.016_bib0175","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41564-018-0152-4","article-title":"New activities for old antibiotics","volume":"3","author":"Cohen","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jiph.2021.01.016_bib0180","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41564-018-0138-2","article-title":"Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner","volume":"3","author":"Gopinath","year":"2018","journal-title":"Nat Microbiol"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034121000319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034121000319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:07:41Z","timestamp":1761750461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034121000319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1876034121000319"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2021.01.016","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2021.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}